# Liraglutide

NDC: 70377-095
Generic name: liraglutide
Labeler / Manufacturer: Biocon Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260327

FDA application: ANDA217063

## Active ingredients

- LIRAGLUTIDE: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70377-095"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70377-095
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b898330-eca1-f60a-71d2-b91716e336ed